Jyothi Rengarajan

9PUBLICATIONS
20CO-AUTHORS
Tumour immunologyMedical devicesNanotoxicology, health and safetyMechanobiologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 18, 2026
The host immune response to Mycobacterium tuberculosis determining protection or disease progression.

|Apr 17, 2026
Multimodal profiling reveals Mycobacterium tuberculosis restricts lung mitochondrial immunometabolism to promote pathogenesis.

|Dec 12, 2025
Concurrent TB and HIV therapies control TB reactivation during co-infection but not chronic immune activation.

Riti Sharan, Yi Zou, Bindu Singh

|Mar 11, 2025
Alveolar macrophages from persons with HIV mount impaired TNF signaling networks to M. tuberculosis infection.

Khanyisile Kgoadi, Prashant Bajpai, Chris C Ibegbu

|Sep 11, 2024
Concurrent TB and HIV therapies effectively control clinical reactivation of TB during co-infection but fail to eliminate chronic immune activation.

Riti Sharan, Yi Zou, Zhao Lai

|Oct 25, 2019
Isoniazid and Rifapentine Treatment Eradicates Persistent Mycobacterium tuberculosis in Macaques.

Taylor W Foreman, Allison N Bucşan, Smriti Mehra

Pageof 2

Frequent Collaborators

4 joint publications

Deepak Kaushal

2 joint publications

Shabaana Khader

1 joint publications

Jonathan Kevin Sia

1 joint publications

Melanie J Quezada